Literature DB >> 11243729

Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21--q23 and is associated with a common polymorphism in LMNA in Pima Indians.

C Weyer1, J K Wolford, R L Hanson, J E Foley, P A Tataranni, C Bogardus, R E Pratley.   

Abstract

Large subcutaneous abdominal adipocyte size (s.c. abd. AS) is associated with insulin resistance and predicts type 2 diabetes in Pima Indians. Because type 2 diabetes is familial, we aimed to determine whether mean s.c. abd. AS is also familial and if so, to identify chromosomal regions linked to this measure. Body composition (hydrodensitometry) and mean s.c. abd. AS (fat biopsy) were measured in 295 Pima Indians (179 with normal, 80 with impaired, and 36 with diabetic glucose tolerance) representing 164 nuclear families. Mean s.c. abd. AS, adjusted for age, sex, and percentage body fat was a familial trait (heritability h(2) = 0.48, P < 0.0001). A genome-wide autosomal scan revealed suggestive evidence for linkage (LOD 1.73) of adjusted mean s.c. abd. AS to chromosome 1q21--q23, a region containing LMNA, the gene encoding for the nuclear envelope proteins lamin A/C. Rare mutations in LMNA were recently shown to underlie familial partial lipodystrophy (FPLD), a syndrome characterized by regional loss of adipose tissue, insulin resistance, and glucose intolerance. A common (allelic frequency 0.43) single nucleotide polymorphism (silent 1908C --> T substitution) in exon 10 of LMNA (GenBank X03444) was associated with reduced age-, sex- and percentage body fat-adjusted mean s.c. abd. AS [0.80 +/- 0.17 (CC), 0.76 +/- 0.15 (CT), 0.73 +/- 0.16 (TT) microg lipid/cell, P < 0.05 for CC vs TT]. These findings indicate that approximately half of the variance in mean s.c. abd. AS can be attributed to familial factors and that genetic variation in LMNA might not only underlie rare cases of FPLD, but may also contribute to variation in adipocyte size in the general population. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243729     DOI: 10.1006/mgme.2001.3147

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  20 in total

1.  Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients.

Authors:  Bjorn Eliasson; Ulf Smith; Shawn Mullen; Samuel W Cushman; Arthur S Sherman; Jian Yang
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

2.  Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.

Authors:  M Lundgren; M Svensson; S Lindmark; F Renström; T Ruge; J W Eriksson
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

3.  The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients.

Authors:  Jian Yang; Bjorn Eliasson; Ulf Smith; Samuel W Cushman; Arthur S Sherman
Journal:  Obesity (Silver Spring)       Date:  2012-01-12       Impact factor: 5.002

4.  Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.

Authors:  Guoping Li; Antonio Hernandez-Ono; Rosanne M Crooke; Mark J Graham; Henry N Ginsberg
Journal:  Metabolism       Date:  2011-12-29       Impact factor: 8.694

5.  The Val81 missense mutation of the melanocortin 3 receptor gene, but not the 1908c/T nucleotide polymorphism in lamin A/C gene, is associated with hyperleptinemia and hyperinsulinemia in obese Greek caucasians.

Authors:  N Yiannakouris; L Melistas; M Kontogianni; K Heist; C S Mantzoros
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

6.  Adipocyte morphology and implications for metabolic derangements in acquired obesity.

Authors:  S Heinonen; L Saarinen; J Naukkarinen; A Rodríguez; G Frühbeck; A Hakkarainen; J Lundbom; N Lundbom; K Vuolteenaho; E Moilanen; P Arner; S Hautaniemi; A Suomalainen; J Kaprio; A Rissanen; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2014-02-19       Impact factor: 5.095

7.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study.

Authors:  Benedicte Fontaine-Bisson; Marie-Christine Alessi; Noemie Saut; Frederic Fumeron; Michel Marre; Anne Dutour; Catherine Badens; Nicolas Levy; Jean Tichet; Irene Juhan-Vague; David-Alexandre Trégouët; Beverly Balkau; Pierre-Emmanuel Morange
Journal:  J Mol Med (Berl)       Date:  2009-10-16       Impact factor: 4.599

Review 9.  Adipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51.

Authors:  Judith Toneatto; Nancy L Charó; Natalia M Galigniana; Graciela Piwien-Pilipuk
Journal:  Adipocyte       Date:  2015-05-13       Impact factor: 4.534

10.  Lamin A/C polymorphisms, type 2 diabetes, and the metabolic syndrome: case-control and quantitative trait studies.

Authors:  José L Mesa; Ruth J F Loos; Paul W Franks; Ken K Ong; Jian'an Luan; Stephen O'Rahilly; Nicholas J Wareham; Inês Barroso
Journal:  Diabetes       Date:  2007-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.